Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage

 Background: Mortality of oral anticoagulation-associated ICH is around 60%, with oral anticoagulation increasing the risk of ICH seven to ten-fold compared to no anticoagulation. Current guidelines recommend DOACs (direct oral anticoagulants) as first-line therapy in the treatment of VTE (Venous Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Troyer, Camille, Nguyen, Wesley, Xie, Annie, Wimer, Dexter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925509/
https://www.ncbi.nlm.nih.gov/pubmed/36355324
http://dx.doi.org/10.1007/s11239-022-02715-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925509/
https://www.ncbi.nlm.nih.gov/pubmed/36355324
http://dx.doi.org/10.1007/s11239-022-02715-4

Ejemplares similares